No Detail Found!

Evaluation of the effects of dexmed- etomidine on liver damage secondary to renal ischemia-reperfusion

Author(s)
Kartal Seyfi Department of Anesthesiology and Reanimation, Trabzon Kanuni Education and Research Hospital, University of Healthy Sciences, Trabzon, (Turkey)
Şen Ahmet Department of Anesthesiology and Reanimation, Trabzon Kanuni Education and Research Hospital, University of Healthy Sciences, Trabzon, (Turkey)
Tümkaya Levent Department of Medical Sciences, Histology, Embryology, Faculty of Medicine, University of Recep Tayyip Erdoğan, Rize, (Turkey)
Özdemir Abdullah Department of Anesthesiology and Reanimation, Trabzon Kanuni Education and Research Hospital, University of Healthy Sciences, Trabzon, (Turkey)
Mercantepe Tolga Department of Medical Sciences, Histology, Embryology, Faculty of Medicine, University of Recep Tayyip Erdoğan, Rize, (Turkey)
Yılmaz Adnan Department of Basic Sciences Biochemistry, Faculty of Medicine, University of Recep Tayyip Erdoğan, Rize, (Turkey)
Abstract
Background: The aim of this study was to evaluate the hepatic protective effects of dexmedetomidine in a rat model of renal ischemia-reperfusion (I/R) injury. Methodology: We selected 18 albino rats and randomly divided them into 3 equal groups (n = 6); control group (Group C), ischemia/reperfusion group (Group I/R), and Group D+I/R, in which dexmedetomidine was given and I/R was administered. The right renal pedicle was ligated to induce I/R in Group-I/R and Group-D+I/R, the left renal pedicle was clamped with an atraumatic vascular clamp to induce ischemia for 120 min and then reperfusion was performed for 120 min. In Group D+I/R, dexmedetomidine 100 µ/kg was administered intraperitoneally 30 min before the administration of before renal I/R. Histopathological changes in liver tissue, caspase-3 activity, glutathione activity, and malondialdehyde level were evaluated through serum renal and liver function tests. Results: After ischemia/reperfusion, the levels of malondialdehyde, glutathione, aspartate aminotransaminase, alanine aminotransaminase, blood urea nitrogen, creatinine, and caspase-3 were increased and these parameters were observed to be improved followed by the administration of dexmedetomidine. After ischemia/reperfusion, histopathological deterioration was also observed, and less histopathological deterioration was observed in rats given dexmedetomidine. Conclusion: The effects of renal ischemia-reperfusion on hepatic tissue were evaluated histopathologically, immunologically, and biochemically. It was observed that renal and liver damage occurred after ischemia-reperfusion and dexmedetomidine reduced damages in both kidney and liver.
Publication Details
Page(s) 205-214
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 24, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Dexmedetomidine, liver, Renal Ischemia, Reperfusion
0

Citations

0

Downloads

35

Views